Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2018 • 74,955 citations

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2018 • 6,648 citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

2010 • 2,440 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

2013 • 1,523 citations

Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities

2008 • 1,475 citations

HPV Screening for Cervical Cancer in Rural India

2009 • 1,199 citations

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

2015 • 1,192 citations

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

2019 • 977 citations

Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.

2001 • 481 citations

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

2020 • 417 citations

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

2005 • 359 citations

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

2019 • 350 citations

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

2012 • 271 citations

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

2016 • 260 citations

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study

2014 • 232 citations

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program

2017 • 144 citations

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

2012 • 130 citations

Evidence of synergistic relationships between <scp>HIV</scp> and Human Papillomavirus (<scp>HPV</scp>): systematic reviews and meta‐analyses of longitudinal studies of <scp>HPV</scp> acquisition and clearance by <scp>HIV</scp> status, and of <scp>HIV</scp> acquisition by <scp>HPV</scp> status

2018 • 116 citations

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review

2013 • 111 citations

An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters

2014 • 108 citations

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV‐based primary screening to liquid‐based cytology for cervical cancer

2016 • 84 citations

Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies

2011 • 77 citations

The health and economic impact of scaling cervical cancer prevention in 50 low‐ and lower‐middle‐income countries

2017 • 64 citations

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country

2018 • 62 citations

Guidelines for multi-model comparisons of the impact of infectious disease interventions

2019 • 53 citations

The predicted impact of vaccination on human papillomavirus infections in Australia

2008 • 53 citations

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study

2013 • 51 citations

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control

2019 • 49 citations

When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis

2015 • 47 citations

Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE

2018 • 42 citations

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior

2015 • 21 citations

Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus

2018 • 18 citations

A Two-Step Markov Processes Approach for Parameterization of Cancer State-Transition Models for Low- and Middle-Income Countries

2018 • 17 citations